Baird Reiterates an 'Outperform' on BioMarin Pharmaceutical (BMRN); Clean Commercial Platform/Robust Pipeline
Tweet Send to a Friend
Baird reiterates an 'Outperform' on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a new price target of $45.00.
Analyst, Christopher ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
